Finzati - Logo
OCEA logo

Ocean Biomedical, Inc.

OCEABiotechnology
$0.00
0.00 (0.00%)
EarningsLatest report: Mar 31, 2025
WEAK PROFILEWeakConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Weak historical ratio profile. The current evidence does not support a favorable risk/reward view.
Market Cap
$474,541
Growth
Cash Flow
0/5
Trend
Negative
Evidence
Weak liquidity · 0.02Weak profitability
Financial data as of: Mar 31, 2025, 12:00 AM UTCLast earnings update: Apr 8, 2025, 12:00 AM UTCLast profile update: Sep 4, 2026, 12:17 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$0.00
Change0.00%
Market Cap$474.54K
52W Range0.00 - 0.01
Beta-0.52
Gross Margin0.00%
Oper. Margin0.00%
Profit Margin0.00%
Debt/Eq-0.17
Current Ratio0.02
Quick Ratio0.02
Volume7.78K

Investment DNA

How strong this company looks for long-term investors

33
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
20/100
Growth Potential
Revenue and expansion
50/100
Price Attractiveness
Cheap or expensive today
50/100
Why this score
Weak liquidity · 0.02Weak profitability
Analyst view
No analyst data available now.

Company Overview

IPO: 11/8/2021
Industry: Biotechnology
P/B i: -0.16
Debt / Equity i: -0.17
Operating Margin: 0.00%
Net Margin: 0.00%
ROE i: -
ROIC: -

Financial Health

Score4 / 20
Debt / Equity: -0.17
Current Ratio: 0.02
Quick Ratio: 0.02
Status: HighRisk

Warnings

  • Weak Liquidity
  • Weak quick ratio

Insider Transactions

Recent executive and insider activity

6 high-volume insider sells detected
KATHURIA CHIRINJEEV
Transaction: 10/02/2023
SELL
Change
-500,000
Price
$0.00
Filing
10/06/2023
Type
SELL
AJJARAPU SURENDRA K
Transaction: 03/22/2023
SELL
Change
-1,050,000
Price
$0.00
Filing
03/24/2023
Type
SELL
AJJARAPU SURENDRA K
Transaction: 02/28/2023
BUY
Change
+21,252
Price
Not reported
Filing
03/24/2023
Type
BUY